German pharmaceutical company Boehringer-Ingelheim has finally come up with a way to act on its offer to provide Viramune free of charge to help African countries prevent mother-to-child transmission of HIV/AIDS, the 'Wall Street Journal' reported on Friday. Since the company announced its offer last year, it had been "frustrated" that few countries or health programmes came forward to accept the offer. But according to the Journal, a new application process developed by Dublin-based Axios International "addresses several major stumbling blocks that have impeded access to Viramune".